Cargando…
Long‐Term Follow‐Up of Idiopathic Ventricular Fibrillation in a Pediatric Population: Clinical Characteristics, Management, and Complications
BACKGROUND: The natural history and long‐term outcome in pediatric patients with idiopathic ventricular fibrillation (IVF) are poorly characterized. We sought to define the clinical characteristics and long‐term outcomes of a pediatric cohort with an initial diagnosis of IVF. METHODS AND RESULTS: Pa...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6512137/ https://www.ncbi.nlm.nih.gov/pubmed/31057083 http://dx.doi.org/10.1161/JAHA.118.011172 |
_version_ | 1783417662439686144 |
---|---|
author | Frontera, Antonio Vlachos, Konstantinos Kitamura, Takeshi Mahida, Saagar Pillois, Xavier Fahy, Gerard Marquie, Christelle Cappato, Riccardo Stuart, Graham Defaye, Pascal Kaski, Juan Pablo Ector, Joris Maltret, Alice Scanu, Patrice Pasquie, Jean‐Luc Deisenhofer, Isabelle Blankoff, Ivan Scherr, Daniel Manninger, Martin Aizawa, Yoshifusa Koutbi, Linda Denis, Arnaud Pambrun, Thomas Ritter, Philippe Sacher, Frederic Hocini, Meleze Maury, Philippe Jaïs, Pierre Bordachar, Pierre Haïssaguerre, Michel Derval, Nicolas |
author_facet | Frontera, Antonio Vlachos, Konstantinos Kitamura, Takeshi Mahida, Saagar Pillois, Xavier Fahy, Gerard Marquie, Christelle Cappato, Riccardo Stuart, Graham Defaye, Pascal Kaski, Juan Pablo Ector, Joris Maltret, Alice Scanu, Patrice Pasquie, Jean‐Luc Deisenhofer, Isabelle Blankoff, Ivan Scherr, Daniel Manninger, Martin Aizawa, Yoshifusa Koutbi, Linda Denis, Arnaud Pambrun, Thomas Ritter, Philippe Sacher, Frederic Hocini, Meleze Maury, Philippe Jaïs, Pierre Bordachar, Pierre Haïssaguerre, Michel Derval, Nicolas |
author_sort | Frontera, Antonio |
collection | PubMed |
description | BACKGROUND: The natural history and long‐term outcome in pediatric patients with idiopathic ventricular fibrillation (IVF) are poorly characterized. We sought to define the clinical characteristics and long‐term outcomes of a pediatric cohort with an initial diagnosis of IVF. METHODS AND RESULTS: Patients were included from an International Registry of IVF (consisting of 496 patients). Inclusion criteria were: (1) VF with no identifiable cause following comprehensive analysis for ischemic, electrical or structural heart disease and (2) age ≤16 years. These included 54 pediatric IVF cases (age 12.7±3.7 years, 59% male) among whom 28 (52%) had a previous history of syncope (median 2 syncopal episodes [interquartile range 1]). Thirty‐six (67%) had VF in situations associated with high adrenergic tone. During a median 109±12 months of follow‐up, 31 patients (57%) had recurrence of ventricular arrhythmias, mainly VF. Two patients developed phenotypic expression of an inherited arrhythmia syndrome during follow‐up (hypertrophic cardiomyopathy and long QT syndrome, respectively). A total of 15 patients had positive genetic testing for inherited arrhythmia syndromes. Ten patients (18%) experienced device‐related complications. Three patients (6%) died, 2 due to VF storm. CONCLUSIONS: In pediatric patients with IVF, a minority develop a definite clinical phenotype during long‐term follow‐up. Recurrent VF is common in this patient group. |
format | Online Article Text |
id | pubmed-6512137 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-65121372019-05-20 Long‐Term Follow‐Up of Idiopathic Ventricular Fibrillation in a Pediatric Population: Clinical Characteristics, Management, and Complications Frontera, Antonio Vlachos, Konstantinos Kitamura, Takeshi Mahida, Saagar Pillois, Xavier Fahy, Gerard Marquie, Christelle Cappato, Riccardo Stuart, Graham Defaye, Pascal Kaski, Juan Pablo Ector, Joris Maltret, Alice Scanu, Patrice Pasquie, Jean‐Luc Deisenhofer, Isabelle Blankoff, Ivan Scherr, Daniel Manninger, Martin Aizawa, Yoshifusa Koutbi, Linda Denis, Arnaud Pambrun, Thomas Ritter, Philippe Sacher, Frederic Hocini, Meleze Maury, Philippe Jaïs, Pierre Bordachar, Pierre Haïssaguerre, Michel Derval, Nicolas J Am Heart Assoc Original Research BACKGROUND: The natural history and long‐term outcome in pediatric patients with idiopathic ventricular fibrillation (IVF) are poorly characterized. We sought to define the clinical characteristics and long‐term outcomes of a pediatric cohort with an initial diagnosis of IVF. METHODS AND RESULTS: Patients were included from an International Registry of IVF (consisting of 496 patients). Inclusion criteria were: (1) VF with no identifiable cause following comprehensive analysis for ischemic, electrical or structural heart disease and (2) age ≤16 years. These included 54 pediatric IVF cases (age 12.7±3.7 years, 59% male) among whom 28 (52%) had a previous history of syncope (median 2 syncopal episodes [interquartile range 1]). Thirty‐six (67%) had VF in situations associated with high adrenergic tone. During a median 109±12 months of follow‐up, 31 patients (57%) had recurrence of ventricular arrhythmias, mainly VF. Two patients developed phenotypic expression of an inherited arrhythmia syndrome during follow‐up (hypertrophic cardiomyopathy and long QT syndrome, respectively). A total of 15 patients had positive genetic testing for inherited arrhythmia syndromes. Ten patients (18%) experienced device‐related complications. Three patients (6%) died, 2 due to VF storm. CONCLUSIONS: In pediatric patients with IVF, a minority develop a definite clinical phenotype during long‐term follow‐up. Recurrent VF is common in this patient group. John Wiley and Sons Inc. 2019-05-06 /pmc/articles/PMC6512137/ /pubmed/31057083 http://dx.doi.org/10.1161/JAHA.118.011172 Text en © 2019 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley. This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
spellingShingle | Original Research Frontera, Antonio Vlachos, Konstantinos Kitamura, Takeshi Mahida, Saagar Pillois, Xavier Fahy, Gerard Marquie, Christelle Cappato, Riccardo Stuart, Graham Defaye, Pascal Kaski, Juan Pablo Ector, Joris Maltret, Alice Scanu, Patrice Pasquie, Jean‐Luc Deisenhofer, Isabelle Blankoff, Ivan Scherr, Daniel Manninger, Martin Aizawa, Yoshifusa Koutbi, Linda Denis, Arnaud Pambrun, Thomas Ritter, Philippe Sacher, Frederic Hocini, Meleze Maury, Philippe Jaïs, Pierre Bordachar, Pierre Haïssaguerre, Michel Derval, Nicolas Long‐Term Follow‐Up of Idiopathic Ventricular Fibrillation in a Pediatric Population: Clinical Characteristics, Management, and Complications |
title | Long‐Term Follow‐Up of Idiopathic Ventricular Fibrillation in a Pediatric Population: Clinical Characteristics, Management, and Complications |
title_full | Long‐Term Follow‐Up of Idiopathic Ventricular Fibrillation in a Pediatric Population: Clinical Characteristics, Management, and Complications |
title_fullStr | Long‐Term Follow‐Up of Idiopathic Ventricular Fibrillation in a Pediatric Population: Clinical Characteristics, Management, and Complications |
title_full_unstemmed | Long‐Term Follow‐Up of Idiopathic Ventricular Fibrillation in a Pediatric Population: Clinical Characteristics, Management, and Complications |
title_short | Long‐Term Follow‐Up of Idiopathic Ventricular Fibrillation in a Pediatric Population: Clinical Characteristics, Management, and Complications |
title_sort | long‐term follow‐up of idiopathic ventricular fibrillation in a pediatric population: clinical characteristics, management, and complications |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6512137/ https://www.ncbi.nlm.nih.gov/pubmed/31057083 http://dx.doi.org/10.1161/JAHA.118.011172 |
work_keys_str_mv | AT fronteraantonio longtermfollowupofidiopathicventricularfibrillationinapediatricpopulationclinicalcharacteristicsmanagementandcomplications AT vlachoskonstantinos longtermfollowupofidiopathicventricularfibrillationinapediatricpopulationclinicalcharacteristicsmanagementandcomplications AT kitamuratakeshi longtermfollowupofidiopathicventricularfibrillationinapediatricpopulationclinicalcharacteristicsmanagementandcomplications AT mahidasaagar longtermfollowupofidiopathicventricularfibrillationinapediatricpopulationclinicalcharacteristicsmanagementandcomplications AT pilloisxavier longtermfollowupofidiopathicventricularfibrillationinapediatricpopulationclinicalcharacteristicsmanagementandcomplications AT fahygerard longtermfollowupofidiopathicventricularfibrillationinapediatricpopulationclinicalcharacteristicsmanagementandcomplications AT marquiechristelle longtermfollowupofidiopathicventricularfibrillationinapediatricpopulationclinicalcharacteristicsmanagementandcomplications AT cappatoriccardo longtermfollowupofidiopathicventricularfibrillationinapediatricpopulationclinicalcharacteristicsmanagementandcomplications AT stuartgraham longtermfollowupofidiopathicventricularfibrillationinapediatricpopulationclinicalcharacteristicsmanagementandcomplications AT defayepascal longtermfollowupofidiopathicventricularfibrillationinapediatricpopulationclinicalcharacteristicsmanagementandcomplications AT kaskijuanpablo longtermfollowupofidiopathicventricularfibrillationinapediatricpopulationclinicalcharacteristicsmanagementandcomplications AT ectorjoris longtermfollowupofidiopathicventricularfibrillationinapediatricpopulationclinicalcharacteristicsmanagementandcomplications AT maltretalice longtermfollowupofidiopathicventricularfibrillationinapediatricpopulationclinicalcharacteristicsmanagementandcomplications AT scanupatrice longtermfollowupofidiopathicventricularfibrillationinapediatricpopulationclinicalcharacteristicsmanagementandcomplications AT pasquiejeanluc longtermfollowupofidiopathicventricularfibrillationinapediatricpopulationclinicalcharacteristicsmanagementandcomplications AT deisenhoferisabelle longtermfollowupofidiopathicventricularfibrillationinapediatricpopulationclinicalcharacteristicsmanagementandcomplications AT blankoffivan longtermfollowupofidiopathicventricularfibrillationinapediatricpopulationclinicalcharacteristicsmanagementandcomplications AT scherrdaniel longtermfollowupofidiopathicventricularfibrillationinapediatricpopulationclinicalcharacteristicsmanagementandcomplications AT manningermartin longtermfollowupofidiopathicventricularfibrillationinapediatricpopulationclinicalcharacteristicsmanagementandcomplications AT aizawayoshifusa longtermfollowupofidiopathicventricularfibrillationinapediatricpopulationclinicalcharacteristicsmanagementandcomplications AT koutbilinda longtermfollowupofidiopathicventricularfibrillationinapediatricpopulationclinicalcharacteristicsmanagementandcomplications AT denisarnaud longtermfollowupofidiopathicventricularfibrillationinapediatricpopulationclinicalcharacteristicsmanagementandcomplications AT pambrunthomas longtermfollowupofidiopathicventricularfibrillationinapediatricpopulationclinicalcharacteristicsmanagementandcomplications AT ritterphilippe longtermfollowupofidiopathicventricularfibrillationinapediatricpopulationclinicalcharacteristicsmanagementandcomplications AT sacherfrederic longtermfollowupofidiopathicventricularfibrillationinapediatricpopulationclinicalcharacteristicsmanagementandcomplications AT hocinimeleze longtermfollowupofidiopathicventricularfibrillationinapediatricpopulationclinicalcharacteristicsmanagementandcomplications AT mauryphilippe longtermfollowupofidiopathicventricularfibrillationinapediatricpopulationclinicalcharacteristicsmanagementandcomplications AT jaispierre longtermfollowupofidiopathicventricularfibrillationinapediatricpopulationclinicalcharacteristicsmanagementandcomplications AT bordacharpierre longtermfollowupofidiopathicventricularfibrillationinapediatricpopulationclinicalcharacteristicsmanagementandcomplications AT haissaguerremichel longtermfollowupofidiopathicventricularfibrillationinapediatricpopulationclinicalcharacteristicsmanagementandcomplications AT dervalnicolas longtermfollowupofidiopathicventricularfibrillationinapediatricpopulationclinicalcharacteristicsmanagementandcomplications |